Journal of the American Academy of Dermatology · 2006
Systematic review of rosacea treatments.
СтатьяСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
van Zuuren Esther J, Gupta Aditya K, Gover Melissa D, Graber Mark, Hollis Sally
Аннотация
BACKGROUND: Rosacea is a common chronic skin and ocular condition. It is unclear which treatments are most effective. We have conducted a Cochrane review of rosacea therapies. This article is a distillation of that work.
OBJECTIVE: We sought to assess the evidence for the efficacy and safety of rosacea therapies.
METHODS: Multiple databases were systematically searched. Randomized controlled trials in people with moderate to severe rosacea were included. Study selection, assessment of methodologic quality, data extraction, and analysis were carried out by two independent researchers.
RESULTS: In all, 29 studies met inclusion criteria. Topical metronidazole is more effective than placebo (odds ratio 5.96, 95% confidence interval 2.95-12.06). Azelaic acid is more effective than placebo (odds ratio 2.45, 95% confidence interval 1.82-3.28). Firm conclusions could not be drawn about other therapies.
LIMITATIONS: The quality of the studies was generally poor.
CONCLUSIONS: There is evidence that topical metronidazole and azelaic acid are effective. There is some evidence that oral metronidazole and tetracycline are effective. More well-designed, randomized controlled trials are required to provide better evidence of the efficacy and safety of other rosacea therapies.
OBJECTIVE: We sought to assess the evidence for the efficacy and safety of rosacea therapies.
METHODS: Multiple databases were systematically searched. Randomized controlled trials in people with moderate to severe rosacea were included. Study selection, assessment of methodologic quality, data extraction, and analysis were carried out by two independent researchers.
RESULTS: In all, 29 studies met inclusion criteria. Topical metronidazole is more effective than placebo (odds ratio 5.96, 95% confidence interval 2.95-12.06). Azelaic acid is more effective than placebo (odds ratio 2.45, 95% confidence interval 1.82-3.28). Firm conclusions could not be drawn about other therapies.
LIMITATIONS: The quality of the studies was generally poor.
CONCLUSIONS: There is evidence that topical metronidazole and azelaic acid are effective. There is some evidence that oral metronidazole and tetracycline are effective. More well-designed, randomized controlled trials are required to provide better evidence of the efficacy and safety of other rosacea therapies.
Предметные рубрики MeSH
Administration, CutaneousAdministration, OralAnti-Bacterial AgentsBenzoyl PeroxideCosmeticsDicarboxylic AcidsDietDouble-Blind MethodDrug Therapy, CombinationHumansMetronidazoleOmeprazolePermethrinRandomized Controlled Trials as TopicResearch DesignRosaceaSingle-Blind MethodSunscreening AgentsTetracyclinesTreatment Outcome